Olimel E

Valine, Alanine, Arginine, Histidine, Isoleucine, Leucine, Methionine, Phenylalanine, Proline, Serin, the active ingredient in Olimel E, is a mixture of essential and non‑essential amino acids presented as a powder for oral use. It supports metabolic functions and protein synthesis in patients requiring nutritional supplementation.

GNH USA supplies Olimel E as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals and pharmacies worldwide.

Olimel E provides amino acid supplementation that supports several clinical conditions where protein turnover is increased. - Critical illness: helps maintain nitrogen balance and supports tissue repair. - Post‑operative recovery: aids in wound healing and muscle preservation. - Chronic kidney disease on dialysis: supplies essential amino acids lost during treatment. - Malnutrition in the elderly: improves overall nutritional status. - Severe burns: contributes to protein synthesis required for skin regeneration.

Adverse reactions to amino‑acid mixtures are generally mild and related to the gastrointestinal tract or hypersensitivity.

Common Side Effects: - Nausea: mild, transient upset stomach. - Diarrhea: loose stools, usually self‑limiting. - Abdominal discomfort: cramping or bloating. - Metallic taste: transient alteration in taste perception. - Headache: mild and short‑lasting. - Injection site irritation: redness or mild pain if administered via feeding tube.

Serious or Rare Side Effects: - Anaphylaxis: severe allergic reaction requiring immediate medical attention. - Hyperammonemia: elevated blood ammonia levels in patients with severe liver dysfunction. - Metabolic acidosis: rare disturbance of acid‑base balance. - Severe electrolyte imbalance: uncommon but possible with high‑dose regimens. - Renal impairment worsening: in patients with pre‑existing kidney disease. - Thromboembolic events: extremely rare, reported in isolated cases.

When prescribing Olimel E, clinicians should consider patient‑specific factors and monitor for potential complications. - Renal function: assess baseline kidney performance and adjust dosage if needed. - Hepatic function: evaluate liver status, especially in patients prone to hyperammonemia. - Allergic history: verify no known hypersensitivity to any amino acid component. - Concomitant nutrition: coordinate with total parenteral or enteral nutrition regimens to avoid excess protein. - Metabolic disorders: use caution in patients with inborn errors of amino‑acid metabolism. - Store at ambient temperature: keep in original container, protect from moisture and direct sunlight.

Amino‑acid mixtures can influence the absorption or metabolism of certain medicines; monitoring is recommended.

Major Interactions (Avoid): - Levodopa: may reduce central availability of levodopa, diminishing Parkinson's symptom control. - Anticonvulsants (e.g., phenobarbital): can increase amino‑acid catabolism, lowering therapeutic effect. - High‑dose insulin: risk of hypoglycaemia when large protein loads shift glucose utilization.

Moderate Interactions (Monitor Closely): - Thyroid hormones: amino acids may affect thyroid‑binding protein levels, requiring dose checks. - Warfarin: protein intake changes can alter INR stability. - Diuretics: increased nitrogen load may impact electrolyte balance. - Oral contraceptives: potential minor reduction in plasma protein binding. - Antibiotics (e.g., tetracycline): chelation with calcium in the mixture may reduce absorption.